Abstract
Schizophrenia is considered a multifactorial disease, where one of the pathogenetic links is oxidative stress; however, the results of studies are often contradictory, largely due to significant heterogeneity among study methods. The present study was undertaken to compare the levels of oxidative stress markers in the peripheral blood of patients with a first episode of schizophrenia (FES) and in healthy volunteers (HV). The study included 50 patients with FES and 37 HV. Blood samples were collected for spectrophotometric assessment of reduced glutathione (GSH), superoxide dismutase (SOD), catalase (CAT), malondialdehyde (MDA), aldehyde-2,4-dinitrophenylhydrazone (ADNPH), and ketone-2,4-dinitrophenylhydrazone (KDNPH) in blood plasma. Results showed that in patients with FES compared with HV, a significant decrease in CAT activity and an increase in oxidative modification of proteins (OMP) were found. In both groups, a significant increase in the level of MDA with age was revealed. In patients, the GSH plasma level was inversely proportional to the ADNPH level, and SOD activity was directly proportional to the KDNPH level. In volunteers there was no such correlation; however, there was a direct correlation between CAT activity and the levels of OMP and MDA. In both groups, a moderate direct correlation between peroxidation products was observed. The results confirm that a redox imbalance (a deficiency of antioxidants, in particular CAT, and excess OMP) may be a pathogenetic link in schizophrenia, which is manifested already at an early stage of the disease.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data Availability
The data used to support the findings of this study are available from the corresponding author upon request.
References
Aguilera G, Colín-González AL, Rangel-López E, Chavarría A, Santamaría A (2018) Redox signaling, neuroinflammation, and neurodegeneration. Antioxid Redox Signal 28(18):1626–1651. https://doi.org/10.1089/ars.2017.7099
An H, Du X, Huang X, Qi L, Jia Q, Yin G, Xiao C, Huang XF, Ning Y, Cassidy RM, Wang L, Soares JC, Zhang XY (2018) Obesity, altered oxidative stress, and clinical correlates in chronic schizophrenia patients. Transl Psychiatry 8(1):258. https://doi.org/10.1038/s41398-018-0303-7
Arutyunyan AV, Dubinina EE, Zybina NN (2000) Methods for assessing free radical oxidation and the body antioxidant system: Guidelines. Foliant, St-Petersburg
Barron H, Hafizi S, Andreazza A, Mizrahi R (2017) Neuroinflammation and oxidative stress in psychosis and psychosis risk. Int J Mol Sci 18(3):651. https://doi.org/10.3390/ijms18030651
Borrás C, Gambini J, López-Grueso R, Pallardó FV, Viña J (2010) Direct antioxidant and protective effect of estradiol on isolated mitochondria. Biochim Biophys Acta 1802(1):205–211. https://doi.org/10.1016/j.bbadis.2009.09.007
Cenini G, Lloret A, Cascella R (2019) Oxidative stress in neurodegenerative diseases: From a mitochondrial point of view. Oxid Med Cell Longev 2019:2105607. https://doi.org/10.1155/2019/2105607
Conus P, Seidman LJ, Fournier M, Xin L, Cleusix M, Baumann PS, Ferrari C, Cousins A, Alameda L, Gholam-Rezaee M, Golay P, Jenni R, Woo TW, Keshavan MS, Eap CB, Wojcik J, Cuenod M, Buclin T, Gruetter R, Do KQ (2018) N-acetylcysteine in a double-blind randomized placebo-controlled trial: Toward biomarker-guided treatment in early psychosis. Schizophr Bull 44(2):317–327. https://doi.org/10.1093/schbul/sbx093
Cost EA, Smirnova LG (1964) Guidelines for clinical laboratory research. Medicine, Moscow
Dietrich-Muszalska A, Malinowska J, Olas B, Głowacki R, Bald E, Wachowicz B, Rabe-Jabłońska J (2012) The oxidative stress may be induced by the elevated homocysteine in schizophrenic patients. Neurochem Res 37(5):1057–1062. https://doi.org/10.1007/s11064-012-0707-3
Dubinina EE, Shedrina LV, Mazo GE (2018) The basic biochemical aspects of the pathogenesis of depression Part 1. Advances in physiological sciences 49(1):28–49
Do KQ, Trabesinger AH, Kirsten-Krüger M, Lauer CJ, Dydak U, Hell D, Holsboer F, Boesiger P, Cuénod M (2000) Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo. Eur J Neurosci 12(10):3721–3728. https://doi.org/10.1046/j.1460-9568.2000.00229.x
Dubinina EE, Burmistrov SO, Khodov DA, Porotov IG (1995) Oxidative modification of human serum proteins. Methods for its determination. Questions of medical chemistry 41(1):24–26
Dubinina EE (2006) Products of oxygen metabolism in the functional activity of the cells (the life and death, creation and destruction). Medicinskaja pressa, St-petersburg, physiological and biochemical aspects of the clinical
Đorđević VV, Lazarević D, Ćosić V, Knežević M, Đorđević VB (2017) Age-related changes of superoxide dismutase activity in patients with schizophrenia. Vojnosanit Pregl 74(1):31–37. https://doi.org/10.2298/VSP141202142D
Flatow J, Buckley P, Miller BJ (2013) Meta-analysis of oxidative stress in schizophrenia. Biol Psychiatry 74(6):400–409. https://doi.org/10.1016/j.biopsych.2013.03.018
Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226(1):497–509
Gama CS, Salvador M, Andreazza AC, Kapczinski F, Silva Belmonte-de-Abreu P (2006) Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia: a study of patients treated with haloperidol or clozapine. Prog Neuropsychopharmacol Biol Psychiatry 30:512–515. https://doi.org/10.1016/j.pnpbp.2005.11.009
González-Blanco L, García-Portilla MP, García-Álvarez L, de la Fuente-Tomás L, Iglesias García C, Sáiz PA, Rodríguez-González S, Coto-Montes A, Bobes J (2018) Oxidative stress biomarkers and clinical dimensions in first 10 years of schizophrenia. Rev Psiquiatr Salud Ment 11(3):130–140. https://doi.org/10.1016/j.rpsm.2018.03.003
Gonzalez-Liencres C, Tas C, Brown EC, Erdin S, Onur E, Cubukcoglu Z, Aydemir O, Esen-Danaci A, Brüne M (2014) Oxidative stress in schizophrenia: a case-control study on the effects on social cognition and neurocognition. BMC Psychiatry 14:268. https://doi.org/10.1186/s12888-014-0268-x
Góth L, Vitai M (1996) Hypocatalasemia in hospital patients. Clin Chem 42(2):341–342
Hardingham GE, Do KQ (2016) Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis. Nat Rev Neurosci 17(2):125–134. https://doi.org/10.1038/nrn.2015.19
Ivanova SA, Smirnova LP, Shchigoreva YG, Boiko AS, Semke AV, Bokhan NA, Uzbekov MG (2014) Glucose-6-phosphate dehydrogenase and catalase activities in erythrocytes of schizophrenic patients under pharmacotherapy with traditional antipsychotics. Neurochem J 31(1):79–83
Joshi YB, Praticò D (2014) Lipid peroxidation in psychiatric illness: overview of clinical evidence. Oxid Med Cell Longev 2014:828702. https://doi.org/10.1155/2014/828702
Kale A, Joshi SR, Mahadik SP (2010) Novel mechanism for oxidative stress in neurodevelopmental pathophysiology and course of schizophrenia. Molecular aspects of neurodegeneration and neuroprotection 19:102–120. https://doi.org/10.2174/978160805092511101010102
Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S, Stadtman ER (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186:464–478. https://doi.org/10.1016/0076-6879(90)86141-h
Matsuzawa D, Obata T, Shirayama Y, Nonaka H, Kanazawa Y, Yoshitome E, Takanashi J, Matsuda T, Shimizu E, Ikehira H, Iyo M, Hashimoto K (2008) Negative correlation between brain glutathione level and negative symptoms in schizophrenia: a 3T 1HMRS study. PLoS One 3(4):e1944. https://doi.org/10.1371/journal.pone.0001944
Nandi A, Yan LJ, Jana CK, Das N (2019) Role of catalase in oxidative stress- and age-associated degenerative diseases. Oxid Med Cell Longev 11(2019):9613090. https://doi.org/10.1155/2019/9613090
Nucifora LG, Tanaka T, Hayes LN, Kim M, Lee BJ, Matsuda T, Nucifora FC Jr, Sedlak T, Mojtabai R, Eaton W, Sawa A (2017) Reduction of plasma glutathione in psychosis associated with schizophrenia and bipolar disorder in translational psychiatry. Transl Psychiatry 7(8):e1215. https://doi.org/10.1038/tp.2017.178
Reyazuddin M, Azmi SA, Islam N, Rizvi A (2014) Oxidative stress and level of antioxidant enzymes in drug-naive schizophrenics. Indian J Psychiatry 56(4):344–349. https://doi.org/10.4103/0019-5545.146516
Rukmini MS, D’Souza B, D’Souza V (2008) Superoxide dismutase and catalase activities and their correlation with malondialdehyde in schizophrenic patients. Indian J Clin Biochem 19(2):114–118. https://doi.org/10.1007/BF02894268
Shcherbatyuk TG, Lyakhova AA, Zhukova ES, Zhilyaeva TV, Piatoikina AS, Semennov IV, Gapeyev AB (2020) Activity of free radical processes in patients with first episode of schizophrenia. Russ J Bio Phys Chem 5(3):474–480
Stadtman ER, Levine RL (2000) Protein oxidation. Ann N Y Acad Sci 899:191–208. https://doi.org/10.1111/j.1749-6632.2000.tb06187.x
Terpstra M, Vaughan TJ, Ugurbil K, Lim KO, Schulz SC, Gruetter R (2005) Validation of glutathione quantitation from STEAM spectra against edited 1H NMR spectroscopy at 4T: application to schizophrenia. MAGMA 18(5):276–282. https://doi.org/10.1007/s10334-005-0012-0
Versace A, Andreazza AC, Young LT, Fournier JC, Almeida JR, Stiffler RS, Lockovich JC, Aslam HA, Pollock MH, Park H, Nimgaonkar VL, Kupfer DJ, Phillips ML (2014) Elevated serum measures of lipid peroxidation and abnormal prefrontal white matter in euthymic bipolar adults: toward peripheral biomarkers of bipolar disorder. Mol Psychiatry 19(2):200–208. https://doi.org/10.1038/mp.2012.188
Zhang XY, Tan YL, Cao LY, Wu GY, Xu Q, Shen Y, Zhou DF (2006) Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics. Schizophr Res 81:291–300
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of Interest
The authors declare no conflict of interest regarding the content of this article.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Piatoikina, A.S., Lyakhova, A.A., Semennov, I.V. et al. Association of antioxidant deficiency and the level of products of protein and lipid peroxidation in patients with the first episode of schizophrenia. J Mol Neurosci 72, 217–225 (2022). https://doi.org/10.1007/s12031-021-01884-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-021-01884-w